Recurrent Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Treatment: Stuck between a Rock and a Hard Place

Clin J Am Soc Nephrol. 2021 Mar 8;16(3):345-347. doi: 10.2215/CJN.00950121. Epub 2021 Feb 19.

Authors

Jonathan A Bolaños¹, Stephen L Seliger

Affiliation

¹ Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, and Medical Care Clinical Center, Veterans Affairs Maryland Healthcare System, Baltimore, Maryland.

No abstract available

Keywords: cardiovascular disease; hyperkalemia; renin angiotensin system.

Publication types

Editorial
Comment

MeSH terms

Aldosterone
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Humans
Hyperkalemia*
Renin-Angiotensin System

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Aldosterone

Associated data

ClinicalTrials.gov/NCT03888066